Cargando…

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival

OBJECTIVE: Type 2 diabetes is associated with an increased risk of several types of cancer and with reduced survival after cancer diagnosis. We examined the hypotheses that survival after a diagnosis of solid-tumor cancer is reduced in those with diabetes when compared with those without diabetes, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Currie, Craig J., Poole, Chris D., Jenkins-Jones, Sara, Gale, Edwin A.M., Johnson, Jeffrey A., Morgan, Christopher Ll.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263862/ https://www.ncbi.nlm.nih.gov/pubmed/22266734 http://dx.doi.org/10.2337/dc11-1313

Ejemplares similares

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)
por: Holden, Sarah E, et al.
Publicado: (2013)

The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
por: Currie, Craig J., et al.
Publicado: (2012)

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
por: Currie, Craig J., et al.
Publicado: (2013)

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study
por: Morgan, Christopher Ll, et al.
Publicado: (2013)

Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study
por: Holden, Sarah E., et al.
Publicado: (2016)

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
por: Holden, Sarah E, et al.
Publicado: (2011)

Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study
por: Morgan, Christopher Ll., et al.
Publicado: (2019)

Diabetes, Insulin Use, and Cancer Risk: Are Observational Studies Part of the Solution–or Part of the Problem?
por: Johnson, Jeffrey A., et al.
Publicado: (2010)

Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991–2012: A Retrospective, Longitudinal Study
por: Berni, Ellen, et al.
Publicado: (2016)

Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study
por: Morgan, Christopher Ll., et al.
Publicado: (2018)

The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
por: Poole, Chris D, et al.
Publicado: (2008)

Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival
por: Currie, Craig J., et al.
Publicado: (2017)

Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes
por: Orchard, Suzanne G, et al.
Publicado: (2023)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn, Thanida, et al.
Publicado: (2021)

Metformin Cessation and Dementia Incidence
por: Zimmerman, Scott C., et al.
Publicado: (2023)

Associations between Metformin and Aspirin Use on Cancer Incidence and Mortality in Older Adults.
por: Orchard, Suzanne, et al.
Publicado: (2021)

The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)
por: Berni, Ellen R, et al.
Publicado: (2019)

Association of vitamin B(12) deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan
por: Miyan, Zahid, et al.
Publicado: (2020)

Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
por: Koo, Hye Yeon, et al.
Publicado: (2021)

Association between kidney function and mortality among incident metformin users: a retrospective cohort study
por: Schorr, M, et al.
Publicado: (2012)

Childhood cancer in Britain: incidence, survival and mortality
por: Pritchard-Jones, K
Publicado: (2007)

GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
por: Gale, Edwin A.M.
Publicado: (2012)

Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125
por: Gale, Edwin A.M.
Publicado: (2013)

Estimates of cancer incidence, mortality and survival in aboriginal people from NSW, Australia
por: Morrell, Stephen, et al.
Publicado: (2012)

Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases
por: Wang, Chen‐Pin, et al.
Publicado: (2019)

Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis
por: Yang, Ting, et al.
Publicado: (2015)

Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status
por: Berni, Ellen, et al.
Publicado: (2018)

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
por: Libby, Gillian, et al.
Publicado: (2009)

Solid Dose Form of Metformin with Ethyl Eicosapentaenoic Acid Does Not Improve Metformin Plasma Availability
por: Burton, Jeffrey H., et al.
Publicado: (2016)

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
por: Cheng, Xu, et al.
Publicado: (2020)

Metformin Protects Cardiovascular Health in People With Diabetes
por: Chen, Chong, et al.
Publicado: (2022)

Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study
por: Elia, Evelin M, et al.
Publicado: (2013)

Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
por: Osman, Mhdia, et al.
Publicado: (2023)

Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
por: Poole, Chris D., et al.
Publicado: (2014)

THE EFFECT OF DISRUPTIVE MEDICAL EVENTS ON MORTALITY IN PEOPLE WITH AND WITHOUT DEMENTIA
por: Hunt, Lauren, et al.
Publicado: (2022)

Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
por: Currie, Craig J., et al.
Publicado: (2019)

Reversing type 1 diabetes with stem cell–derived islets: a step closer to the dream?
por: Butler, Peter C., et al.
Publicado: (2022)

Metformin and COVID-19: From cellular mechanisms to reduced mortality
por: Scheen, A.J.
Publicado: (2020)

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
por: Neuen, Brendon L., et al.
Publicado: (2020)

The Role of Metformin in Ovarian Cancer: Does Metformin Increase Survival in Ovarian Neoplasm?
por: Ahmed, Maimuna F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ths2ornlve7fpifq5r73d3336l